CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 6, 2009, Pages 387-393

  De Oliveira, Karen Brajão ^a   Oda, Julie Massayo Maeda ^a   Voltarelli, Julio Cesar ^b   Nasser, Thiago Franco ^a   Ono, Mario Augusto ^a   Fujita, Thiago Cezar ^a   Matsuo, Tiemi ^a   Watanabe, Maria Angelica Ehara ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; Chemokines; CXCL12 rs1801157 polymorphism; Hodgkin's lymphoma; Non Hodgkin's lymphoma

Indexed keywords

STROMAL CELL DERIVED FACTOR 1;

ADULT; ANGIOGENESIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PROTEIN CLEAVAGE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GROWTH;

ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOKINE CXCL12; FEMALE; GENE FREQUENCY; GENOTYPE; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 73249134987     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20346     Document Type: Article

References (64)

1. Brazil. 2007. Ministry of Health. Secretariat for Health Assistance. National Cancer Institute. Prevention and Surveillance Coordination Unit. Estimate 2008: Brazilian cancer incidence. Rio de Janeiro: NCI, 2007. [http://www.inca.gov.br/estimativa/2008/finalversion.pdf].
2. WHO. World Health Organization. Cancer. Fact Sheet No. 297. 2006. [homepage on the internet]. Geneva: World Health Organization; c2007 [cited 2007 Oct 10]. [http://www.who.int/mediacentre/factsheets/fs297/en/print.html].
3. Luker KE, Luker GD. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 2006;238:30-41.
4. Golay J, Introna M. Chemokines and antagonists in non-Hodgkin's lymphoma. Expert Opin Ther Targets 2008;12:621-635.
5. Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007;98:1652-1658.
6. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
7. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: A cloning strategy for secreted proteins and type I membrane proteins. Science 1993;261:600-603.
8. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-638.
9. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362:697-703.
10. Ratajczak MZ, Majka M, Kucia M, et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003;21:363-371.
11. Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+stem cell recruitment to the liver. J Clin Investig 2003;112:160-169.
12. Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998;393:591-594.
13. Schrader AJ, Lechner O, Templin M, et al. CXCR4/CXCL12 expression and signaling in kidney cancer. Br J Cancer 2002;86:1250-1256.
14. Ponomaryov T, Peled A, Petit I, et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Investig 2000;106:1331-1339.
15. Yun HJ, Jo DY. Production of stromal cell-derived factor-1 (SDF-1) and expression of CXCR4 in human bone marrow endothelial cells. J Korean Med Sci 2003;18:679-685.
16. Ma Q, Jones D, Borghesani PR, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998;95:9448-9453.
17. Barbieri F, Bajetto A, Porcile C, et al. CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation. Ann N Y Acad Sci 2006;1090:332-343.
18. Hattori K, Heissig B, Tashiro K, et al. Plasma elevation of stromal cellderived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001;97:3354-3360.
19. Lane WJ, Dias S, Hattori K, et al. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 2000;96:4152-4159.
20. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: A molecular hub modulating neo-angiogenesis. Trends Immunol 2007;28:299-307.
21. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-393.
22. Balter M. Chemokine mutation slows progression in pathogenesis by a SDF-1 chemokine gene variant. Science 1998;118:681-688.
23. Dubois-Laforgue D, Hendel H, Caillat-Zucman S, et al. A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 2001;50:1211-1213.
24. Reiche EM, Ehara Watanabe MA, Bonametti AM, et al. The effect of stromal cell-derived factor 1 (SDF1/CXCL12) genetic polymorphism on HIV-1 disease progression. Int J Mol Med 2006;18:785-793.
25. De Oliveira CE, Cavassin GG, Perim ADEL, et al. Stromal cell-derived factor-1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients. J Clin Lab Anal 2007;21:49-54.
26. Vairaktaris E, Vylliotis A, Spyridonodou S, et al. A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer. Anticancer Res 2008;28:271-275.
27. Razmkhah M, Doroudchi M, Ghayumi SM, Erfani N, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer 2005;49:311-315.
28. Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 2005;225:261-266.
29. Dimberg J, Hugander A, Löfgren S, Wågsäter D. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int J Mol Med 2007;19:11-15.
30. Kirby LT. DNA Fingerprinting: An Introduction. New York: Stocton Press. 1990.
31. Moura-Gallo CV, Simão TA, Ribeiro FS, Andrada-Serpa MJ, Cardoso LEB, Mendonça GAS. Mutações no gene TP53 em tumores malignos de mama: associação com fatores de risco e características clínico-patológicas, inclusive risco de óbito, em pacientes esidentes no Rio de Janeiro. Rev Bras Epidemiol 2004;7:167-175.
32. Moraes AB, Zanini RR, Turchiello MS, Riboldi J, Medeiros LR. Estudo da sobrevida de pacientes com câncer de mama atendidas no hospital da Universidade Federal de Santa Maria, Rio Grande do Sul, Brasil. Cad Saúde Pública 2006;22:2219-2228.
33. Marinho VFZ, Metze K, Sanches FSF, Rocha GFS, Gobbi H. Marcadores moleculares em câncer de mama preditivos de metástases axilares. Rev Assoc Med Bras 2008;54:203-207.
34. Mauch P, Armitage J, Diehl V, Hoppe R, Weiss L. Hodgkin's Disease. Lippincott: Williams & Wilkins. 1999.
35. Vassallo J, Paes RP, Soares FA, et al. Histological classification of 1,025 cases of Hodgkin's lymphoma from the State of São Paulo, Brazil. Sao Paulo Med J 2005;123:134-136.
36. Ries LAG, Melbert D, Krapcho M, et al (editors). SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD, http://seer.cancer. gov/csr/1975-2005/, based on November 2007 SEER data submission, posted to the SEER web site, 2008.
37. Pracchia LF, Linardi CCG, Buccheri V. Gemcitabine and ifosfamide in the treatment of Hodgkin's lymphoma refractory to or relapsed after multiple therapies. Rev Bras Hematol Hemoter 2007;29:422-424.
38. Costa FPS, Pereira FG, Vassalo J, Freitas LLL, Lorand-Metze I. Diagnosis of non-Hodgkin's lymphoma combining immunophenotyping and fine needle aspiration. Rev Bras Hematol Hemoter 2005;27:16-20.
39. Chang ET, Smedby KE, Zhang SM, et al. Dietary factors and risk of non-Hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev 2005;14:512-520.
40. Arya M, Ahmed H, Silhi N, Williamson M, Patel HR. Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration. Tumour Biol 2007;28:123-131.
41. Vandercappellen J, Damme JV, Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett 2008;267:226-244.
42. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-833.
43. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev 2001;12:313-335.
44. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006;203:2201-2213.
45. Libert F, Parmentier M, Lefort A, Dumont JE, Vassart G. Complete nucleotide sequence of a putative G protein coupled receptor: RDC1. Nucleic Acids Res 1990;18:1917.
46. Libert F, Passage E, Parmentier M, Simons MJ, Vassart G, Mattei MG. Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor. Genomics 1991;11:225-227.
47. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 2003;167:1676-1686.
48. Watanabe MA, De Oliveira Cavassin GG, Orellana MD, et al. SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals. Microb Pathog 2003;35:31-34.
49. Zafiropoulos A, Crikas N, Passam AM, Spandidos DA. Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 2004;41:1-5.
50. Dobrovolskaia MA, Kozlov SV. Inflammation and cancer: When NF-kappaB amalgamates the perilous partnership. Curr Cancer Drug Targets 2005;5:325-344.
51. Bao CH, He QT. Advance of research on SDF-1/CXCR4 axis and angiogenesis in leukemia - Review. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008;16:447-451.
52. Hassan S, Baccarelli A, Salvucci O, Basik M. Plasma stromal cell-derived factor-1: Host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res 2008;14:446-454.
53. Wang J, Loberg R, Taichman RS. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 2006;25:573-587.
54. Zhang C, Cui GH, Liu F, Wu QL, Chen Y. The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma. Zhonghua Yi Xue Za Zhi 2007;87:695-697.
55. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: Non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000;92:1240-1251.
56. Syed AS, Samad FA, ur Rahman M. Large B cell lymphoma - year by year. J Ayub Med Coll Abbottabad 2007;19:121-126.
57. Bosetti C, Levi F, Ferlay J, Lucchini F, Negri E, La Vecchia C. Incidence and mortality from non-Hodgkin lymphoma in Europe: The end of an epidemic? Int J Cancer 2008;123:1917-1923.
58. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m (null) mice. Leukemia 2002;16:1992-2003.
59. Cavassin GGO, De Lucca FL, Delgado André N, et al. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. Blood Cells Mol Dis 2004;33:90-93.
60. Rabkin CS, Yang Q, Goedert JJ, Nguyen G, Mitsuya H, Sei S. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood 1999;93:1838-1842.
61. Sei S, O'Neill DP, Stewart SK, et al. Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma. Cancer Res 2001;61:5028-5037.
62. Corcione A, Ottonello L, Tortolina G, et al. Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. J Natl Cancer Inst 2000;92:628-635.
63. Zeng DF, Kong PY, Chen XH, et al. Expression of stromal cell derived factor-1(SDF-1) and its receptor CXCR4 in hematologic malignancies. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005;13:274-277.
64. Lin T, Tseng HF, Yang CH, et al. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS 2009;13:165-172.